Viridian Therapeutics
VRDN
VRDN
26 hedge funds and large institutions have $8.36M invested in Viridian Therapeutics in 2020 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
22% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 9
30% less capital invested
Capital invested by funds: $11.9M → $8.36M (-$3.59M)
Holders
26
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$238K | |
| 2 | +$116K | |
| 3 | +$87K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$67.4K |
| 5 |
BCV
Banque Cantonale Vaudoise
Lausanne,
Switzerland
|
+$39K |
Top Sellers
| 1 | -$375K | |
| 2 | -$132K | |
| 3 | -$77K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$71K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
-$18K |